Market Place
Sourcing Support
Takeda tees up priority review for storied CMV drug from its $62B Shire buyout
22 May 2021 //
ENDPTS
FDA approves ointment for precancer skin lesions; Takeda nabs priority
15 Dec 2020 //
ENDPTS
Takeda offers Japanese sales, admin staffers early retirement in post-Shire
18 Aug 2020 //
FIERCEPHARMA
Antianxiety & Antidepressant Effects from a Single Dose of Psychedelic Drug
28 Jan 2020 //
PR NEWSWIRE
The top 15 biopharma M&A mistakes of the last decade
03 Dec 2019 //
FIERCE PHARMA
Yumanity snags a CMO as Shire keeps bleeding execs
18 Nov 2019 //
FIERCE BIOTECH
Ipsen grabs new R&D lead as Shire`s neuro head leaves amid Takeda takeover
06 Nov 2019 //
FIERCE BIOTECH
Stada buys Takeda drug bundle to boost Russia business
06 Nov 2019 //
REUTERS
AstraZeneca spinout Entasis nabs Shire exec as CMO
02 Nov 2019 //
FIERCE BIOTECH
Takeda`s rare disease unit suffers on hemophilia, Natpara recall
01 Nov 2019 //
FIERCE PHARMA
Bayer, Pfizer top pharma on social media: report
22 Oct 2019 //
FIERCE PHARMA
Want to win over investors with your M&A deals, pharma? Here`s how: analyst
15 Oct 2019 //
FIERCE PHARMA
Takeda close to sell emerging market, European drugs: report
27 Sep 2019 //
FIERCE PHARMA
AZ`s vet heads to UK biotech as the new CSO; Mallinckrodt touts +ve PhIII data
24 Sep 2019 //
ENDPTS
Combo drugs: latest trend in local pharmaceuticals
19 Aug 2019 //
KOREAMED
Takeda board lays out Shire integration goals
03 Aug 2019 //
BIOPHARMADIVE
Takeda whittles costs, pares down debt as Shire folds in
01 Aug 2019 //
FIERCE PHARMA
Protalix, Chiesi fire up accelerated approval pitch for Fabry disease treatment
07 Jun 2019 //
ENDPTS
Velcade copy, Uloric patent loss will hurt post-Shire Takeda
15 May 2019 //
FIERCE PHARMA
Novartis buys Takeda`s dry eye drug for $3.4 bln
09 May 2019 //
CNBC
Tillman Gerngross isn’t out to impress you with biobucks 3 partner deals
08 May 2019 //
ENDPTS
EU Regulatory Roundup: Shire Raises ‘Substantial Concerns’ About ICH Guidelines
25 Jan 2019 //
RAPS
Rentschler expands biologics capacity with deal for Shire site
19 Dec 2018 //
FIERCE PHARMA
Shinichi Tamura reclaims the helm at Sosei as CEO Peter Bains hits the exit
12 Dec 2018 //
ENDPTS
What do Martin Shkreli, Gilead and Takeda have in common?
06 Dec 2018 //
ENDPTS
Takeda clears final regulatory hurdle for Shire buyout
23 Nov 2018 //
FIERCE PHARMA
Takeda receives clearance from EC for proposed acquisition of Shire
23 Nov 2018 //
BIOSPECTRUM
Shire`s Takhzyro gets off to hot start, boosting immunology sales
03 Nov 2018 //
FIERCE PHARMA
Apitope CEO Keith Martin steps down; Clearside Biomedical taps Spark exec as CMO
27 Oct 2018 //
ENDPTS
Bayer roll-out of haemophilia drug Jivi gathers pace
21 Sep 2018 //
PM LIVE
Shire’s Veyvondi approved in Europe for bleeding disorder
12 Sep 2018 //
PHARMA TIMES
FiercePharmaAsia—Sanofi, Takeda, I-Mab and more
06 Jul 2018 //
FIERCE PHARMA
Pharma shells out $100B on M&A in 2018 so far: report
06 Jul 2018 //
FIERCE PHARMA
Shire Korea launches hereditary angioedema therapy Firazyr
21 Jun 2018 //
KOREABIOMED
Takeda CEO Sees Path to Survival in Shire Megadeal
18 May 2018 //
BLOOMBERG
Takeda to strategically cut R&D after $62B Shire buy: Reuters
17 May 2018 //
FIERCE BIOTECH
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
17 May 2018 //
ENDPTS
Takeda reaches preliminary deal to buy Shire for close to $65B
25 Apr 2018 //
ENDPTS
Shire faces criticism on CEO pay policy as crunch week looms
19 Apr 2018 //
REUTERS
Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles
17 Apr 2018 //
REUTERS
Shire shares rocket up after Takeda says it’s pondering a takeover bid
28 Mar 2018 //
ENDPTS
Tokyo court rejects Shire claim against Roche hemophilia drug
28 Mar 2018 //
REUTERS
Shire links with NanoMedSyn to work on new ERT
26 Mar 2018 //
PHARMA TIMES
Ex-Eli Lilly CFO becomes president of PBM business
23 Mar 2018 //
ENDPTS
Shire CEO sees Microsoft tie-up as outgrowth of digital mission
21 Mar 2018 //
FIERCEPHARMA
Just a Little Patience: In-licensing from Biopharma
20 Mar 2018 //
LIFESCIVC
Shire’s constipation drug under US review
06 Mar 2018 //
PHARMA TIMES
After bagging Shire’s cell therapy castoff, Caladrius stock climbs
06 Mar 2018 //
ENDPTS
Shire claims EU approval for haemophilia A drug Adynovi
15 Jan 2018 //
PMLIVE
Shire CEO Flemming Ornskov is hatching a few new stretch goals for R&D in 2018
11 Jan 2018 //
ENDPTS
Lilly`s CGRP Prospects, Juno On Track, Color- Alnylam`s Greene, Shire`s New CMO
10 Jan 2018 //
PHARMAINTELLIGENCE
Shire separates out neuroscience as it considers its future
10 Jan 2018 //
PMLIVE
Takeover Whispers Boost Shire, Mega Deal to Bring an Early Christmas Present
20 Dec 2017 //
BIOSPACE
Shire expects to be making some Cinryze in-house early next year
31 Oct 2017 //
IN PHARMATECHNOLOGIST
Shire to make genetic disease drug itself to secure supply
27 Oct 2017 //
REUTERS
Shire’s gene therapy candidate receives orphan drug status in the US
26 Oct 2017 //
PMLIVE
EU approves label extension for Shire`s Firazyr for symptomatic treatment
26 Oct 2017 //
PHARMABIZ
Shire’s haemophilia A gene therapy wins Orphan status
26 Oct 2017 //
PHARMA TIMES
Shire’s experimental HAE drug hits phase 3 marks
11 Sep 2017 //
FIERCE BIOTECH
